PT91553A - Processo de preparacao de uma composicao contendo morfina - Google Patents

Processo de preparacao de uma composicao contendo morfina

Info

Publication number
PT91553A
PT91553A PT91553A PT9155389A PT91553A PT 91553 A PT91553 A PT 91553A PT 91553 A PT91553 A PT 91553A PT 9155389 A PT9155389 A PT 9155389A PT 91553 A PT91553 A PT 91553A
Authority
PT
Portugal
Prior art keywords
composition containing
preparation process
containing morphine
morphine
inclusion
Prior art date
Application number
PT91553A
Other languages
English (en)
Other versions
PT91553B (pt
Inventor
Robin Paul Mitchell
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of PT91553A publication Critical patent/PT91553A/pt
Publication of PT91553B publication Critical patent/PT91553B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
PT91553A 1988-08-26 1989-08-25 Processo de preparacao de uma composicao contendo morfina PT91553B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888820327A GB8820327D0 (en) 1988-08-26 1988-08-26 New compositions of matter

Publications (2)

Publication Number Publication Date
PT91553A true PT91553A (pt) 1990-03-08
PT91553B PT91553B (pt) 1995-07-06

Family

ID=10642786

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91553A PT91553B (pt) 1988-08-26 1989-08-25 Processo de preparacao de uma composicao contendo morfina

Country Status (15)

Country Link
US (1) US5387420A (pt)
EP (1) EP0361680B1 (pt)
JP (1) JP2793280B2 (pt)
AT (1) ATE108329T1 (pt)
AU (1) AU613517B2 (pt)
CA (1) CA1338889C (pt)
DE (1) DE68916731T2 (pt)
DK (1) DK421189A (pt)
ES (1) ES2059775T3 (pt)
GB (1) GB8820327D0 (pt)
HU (1) HU206265B (pt)
IE (1) IE63911B1 (pt)
NZ (1) NZ230440A (pt)
PT (1) PT91553B (pt)
ZA (1) ZA896519B (pt)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009473D0 (en) * 1990-04-27 1990-06-20 Beecham Group Plc Pharmaceutical formulation
US5302397A (en) * 1991-11-19 1994-04-12 Amsden Brian G Polymer-based drug delivery system
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US5607940A (en) * 1994-07-18 1997-03-04 Stephen; Robert L. Morphine formulations for use by electromotive administration
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
GB2307857B (en) * 1995-12-04 1999-01-27 Euro Celtique Sa An effervescent formulation
TWI285644B (en) 1997-07-11 2007-08-21 Toray Industries A stable pharmaceutical composition containing a derivative of 4,5-epoxymorphinan and a water-soluble antioxidant, an oil-soluble antioxidant, a synergist, a sugar and a surfactant
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
BRPI0015284B8 (pt) 1999-10-29 2021-05-25 Euro Celtique S/A formulações de hidrocodona de liberação controlada
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR101045144B1 (ko) 2000-10-30 2011-06-30 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) * 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004020220A1 (de) * 2004-04-22 2005-11-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
BRPI0418213A (pt) * 2003-12-31 2007-04-27 Cima Labs Inc forma de dosagem, e, método para tratar dor em um paciente em necessidade do mesmo
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
JP2007517054A (ja) 2003-12-31 2007-06-28 シーマ・ラブス、インコーポレイテッド 概して線状の発泡性経口フェンタニル投薬形態および投与方法
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
CA2671197A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophobic abuse deterrent delivery system
DE102007011485A1 (de) * 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
EP2151241B1 (en) 2007-04-26 2012-03-21 Toray Industries, Inc. Stable solid preparation comprising 4,5-epoxymorphinan derivative
BRPI0906467C1 (pt) 2008-01-25 2021-05-25 Gruenenthal Gmbh forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
LT2273983T (lt) * 2008-05-09 2016-10-25 Grünenthal GmbH Tarpinės miltelių kompozicijos gamybos būdas ir galutinė kieta dozavimo forma naudojant purškalo kietinimo stadija
EP2356989B1 (en) 2008-10-24 2018-02-07 Toray Industries, Inc. Stable tablet containing 4,5-epoxymorphinan derivative
TW201105316A (en) 2009-07-22 2011-02-16 Gruenenthal Gmbh Hot-melt extruded pharmaceutical dosage form
KR101747156B1 (ko) * 2009-07-22 2017-06-27 그뤼넨탈 게엠베하 산화-안정화된 탬퍼-내성 용량형
CN102821757B (zh) * 2010-02-03 2016-01-20 格吕伦塔尔有限公司 通过挤出机制备粉末状药物组合物
MX2013002377A (es) 2010-09-02 2013-04-29 Gruenenthal Gmbh Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
RU2607499C2 (ru) 2010-09-02 2017-01-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, которая содержит анионный полимер
EA201400173A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
EA201400172A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
JP6282261B2 (ja) 2012-04-18 2018-02-21 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 不正使用防止および過量放出防止医薬剤形
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
AU2014273227B2 (en) 2013-05-29 2019-08-15 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
AR096439A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido que contiene una o más partículas
CA2917136C (en) 2013-07-12 2022-05-31 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
JP6480936B2 (ja) 2013-11-26 2019-03-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング クライオミリングによる粉末状医薬組成物の調製
AU2015261060A1 (en) 2014-05-12 2016-11-03 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising Tapentadol
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
MX2017013637A (es) 2015-04-24 2018-03-08 Gruenenthal Gmbh Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
ES2831179T3 (es) * 2015-07-24 2021-06-07 Evonik Operations Gmbh Formulaciones efervescentes de aspartato de ornitina
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2211485A (en) * 1940-08-13 Effervescent acetyl salicylic acid
US3136692A (en) * 1961-06-30 1964-06-09 Strong Cobb Arner Inc Effervescent composition containing polyvinylpyrrolidone
GB1241201A (en) * 1968-07-23 1971-08-04 Sterling Winthrop Group Ltd Improvements in or relating to effervescent pharmaceutical compositions
US4332789A (en) * 1975-12-15 1982-06-01 Hoffmann-La Roche Inc. Pharmaceutical unit dosage forms
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4366159A (en) * 1981-09-08 1982-12-28 Michael Richard Magruder Nalbuphine-narcotic analgesic composition and method of producing analgesia
JPS6165823A (ja) * 1984-09-07 1986-04-04 Kao Corp 直腸投与製剤
JPS61183219A (ja) * 1985-02-07 1986-08-15 Takeda Chem Ind Ltd 発泡組成物の製造法
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
WO1986007547A1 (en) * 1985-06-21 1986-12-31 Gerhard Gergely Process and device for handling processing material and the reaction product manufactured with the aid of the process and/or device
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions

Also Published As

Publication number Publication date
HUT53521A (en) 1990-11-28
ATE108329T1 (de) 1994-07-15
DE68916731D1 (de) 1994-08-18
EP0361680A3 (en) 1990-04-11
AU4081089A (en) 1990-03-01
US5387420A (en) 1995-02-07
IE63911B1 (en) 1995-06-14
JP2793280B2 (ja) 1998-09-03
EP0361680B1 (en) 1994-07-13
DK421189D0 (da) 1989-08-25
ES2059775T3 (es) 1994-11-16
HU206265B (en) 1992-10-28
JPH02160719A (ja) 1990-06-20
IE892749L (en) 1990-02-26
GB8820327D0 (en) 1988-09-28
ZA896519B (en) 1990-05-30
PT91553B (pt) 1995-07-06
DK421189A (da) 1990-02-27
CA1338889C (en) 1997-02-04
AU613517B2 (en) 1991-08-01
DE68916731T2 (de) 1994-12-15
EP0361680A2 (en) 1990-04-04
NZ230440A (en) 1990-10-26

Similar Documents

Publication Publication Date Title
PT91553A (pt) Processo de preparacao de uma composicao contendo morfina
FI904758A0 (fi) Gjuten yta vilken vaexer in i benet.
IL89921A (en) 1,3-dioxolane derivatives and pharmaceutical compositions containing the same
DE69011988D1 (de) Lagerstabile Azadirachtin-Formulierung.
ZA907338B (en) Thienylcarboxylates of amino alcohols
DK500187A (da) Slagfast polymerkomposition
DK135189A (da) Polymer komposition
NO891982L (no) Polymer-sammensetning.
DE68920092D1 (de) Harzzusammensetzung.
BR8704567A (pt) Composicao de resina termofixavel
DE68919875D1 (de) Thermoplastische Zusammensetzung.
DE68924329D1 (de) Stammischungs-Zusammensetzung.
DE68920021D1 (de) Polymerzusammensetzung.
ES2082872T3 (es) Composiciones antiglaucoma que contienen 3-arilcarbonil-1-aminoalquil--1h-indol.
DE68919151D1 (de) Harzzusammensetzung.
DE68911340D1 (de) Harzzusammensetzung.
HUT49793A (en) Herbicide compositions containing n-aryl-tetrahydro-phtalimides as active components and process for producing the active components
DE68924798D1 (de) Harzzusammensetzung.
DE68906407D1 (de) Poly(cyanoarylether) enthaltende zusammensetzung.
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
DE68911597D1 (de) Harzzusammensetzung.
HUT44011A (en) Herbicide compositions containing n-substituted-3,4,5,6-tetrahydro-phtalimide derivatives as active components and process for producing the active components
BR8703792A (pt) Composicao de resina
HUT52763A (en) Herbicide and growth-controlling compositions containing sulfonyl-urea derivatives as active components and process for producing the active components
DE69012882D1 (de) Herstellung von Stickstoffzusammensetzungen.

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19970831